000

JEIL PHARMA HOLDINGS

No trades
See on Supercharts
Market capitalization
‪151.06 B‬KRW
−1040KRW
‪−16.03 B‬KRW
‪794.71 B‬KRW
‪2.10 M‬
Beta (1Y)
0.26

About JEIL PHARMA HOLDINGS

CEO
Sang-Cheol Han
Headquarters
Seoul
Founded
1959
ISIN
KR7002620003
FIGI
BBG000BGY469
Jeil Pharma Holdings, Inc. engages in the management of its subsidiaries. Its services include consulting, rental, and others. The company was founded on March 7, 1959 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 002620 is 10310 KRW — it has increased by 0.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange JEIL PHARMA HOLDINGS stocks are traded under the ticker 002620.
JEIL PHARMA HOLDINGS is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
002620 stock is 3.27% volatile and has beta coefficient of 0.26. Check out the list of the most volatile stocks — is JEIL PHARMA HOLDINGS there?
Yes, you can track JEIL PHARMA HOLDINGS financials in yearly and quarterly reports right on TradingView.
002620 stock has fallen by 2.92% compared to the previous week, the month change is a 3.64% fall, over the last year JEIL PHARMA HOLDINGS has showed a 11.96% decrease.
002620 net income for the last quarter is ‪−26.84 B‬ KRW, while the quarter before that showed ‪−260.15 M‬ KRW of net income which accounts for ‪−10.22 K‬% change. Track more JEIL PHARMA HOLDINGS financial stats to get the full picture.
Today JEIL PHARMA HOLDINGS has the market capitalization of ‪157.81 B‬, it has decreased by 3.85% over the last week.
Yes, 002620 dividends are paid annually. The last dividend per share was 50.00 KRW. As of today, Dividend Yield (TTM)% is 0.49%. Tracking JEIL PHARMA HOLDINGS dividends might help you take more informed decisions.
Like other stocks, 002620 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JEIL PHARMA HOLDINGS stock right from TradingView charts — choose your broker and connect to your account.
002620 reached its all-time high on Jun 15, 2016 with the price of 139000 KRW, and its all-time low was 2090 KRW and was reached on May 25, 2004.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JEIL PHARMA HOLDINGS technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JEIL PHARMA HOLDINGS stock shows the sell signal. See more of JEIL PHARMA HOLDINGS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JEIL PHARMA HOLDINGS EBITDA is ‪24.15 B‬ KRW, and current EBITDA margin is 3.04%. See more stats in JEIL PHARMA HOLDINGS financial statements.